The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate?

by Alisi Anna, Monti Lidia, Corte Claudia, Nobili Valerio, Feldstein Ariel
Published 2011-08-01

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

by Pietrobattista Andrea, Tiribelli Claudio, Vania Andrea, Alisi Anna, Nobili Valerio, Bedogni Giorgio
Published 2009-05-01

Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease

by Mayada Metwally, Ali Bayoumi, Anis Khan, Leon A. Adams, Rocio Aller, Carmelo García-Monzón, María Teresa Arias-Loste, Elisabetta Bugianesi, Luca Miele, Alisi Anna, Olivier Latchoumanin, Shuanglin Han, Shafi Alenizi, Rasha EL Sharkawy, Afaf Elattar, Rocio Gallego-Durán, Janett Fischer, Thomas Berg, Christopher Liddle, Manuel Romero-Gomez, Jacob George, Mohammed Eslam
Published 2021-08-01

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

by Eslam, Mohammed, Alkhouri, Naim, Vajro, Pietro, Baumann, Ulrich, Weiss, Ram, Socha, Piotr, Marcus, Claude, Lee, Way Seah, Kelly, Deirdre, Porta, Gilda, El-Guindi, Mohamed A., Alisi, Anna, Mann, Jake P., Mouane, Nezha, Baur, Louise A., Dhawan, Anil, George, Jacob
Published 2021

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.

by Eslam, Mohammed, Alkhouri, Naim, Vajro, Pietro, Baumann, Ulrich, Weiss, Ram, Socha, Piotr, Marcus, Claude, Lee, Way Seah, Kelly, Deirdre, Porta, Gilda, El-Guindi, Mohamed A, Alisi, Anna, Mann, Jake P, Mouane, Nezha, Baur, Louise A, Dhawan, Anil, George, Jacob
Published 2022

Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1.

by Matsushita, Noriko, Hassanein, Mohamed T, Martinez-Clemente, Marcos, Lazaro, Raul, French, Samuel W, Xie, Wen, Lai, Keane, Karin, Michael, Tsukamoto, Hidekazu
Published 2017

Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.

by Mann, Jake P, De Vito, Rita, Mosca, Antonella, Alisi, Anna, Armstrong, Matthew J, Raponi, Massimiliano, Baumann, Ulrich, Nobili, Valerio
Published 2018

Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study.

by Mann, Jake P, Jenkins, Benjamin, Furse, Samuel, Snowden, Stuart G, Alisi, Anna, Draijer, Laura G, Karnebeek, Kylie, Kelly, Deirdre A, Koot, Bart G, Mosca, Antonella, Salvestrini, Camilla, van Mourik, Indra, Vreugdenhil, Anita, Zilbauer, Matthias, Koulman, Albert, EU-PNAFLD investigators^
Published 2022

Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fi...

by Hudert, Christian A, Adams, Leon A, Alisi, Anna, Anstee, Quentin M, Crudele, Annalisa, Draijer, Laura G, EU-PNAFLD investigators, Furse, Samuel, Hengstler, Jan G, Jenkins, Benjamin, Karnebeek, Kylie, Kelly, Deirdre A, Koot, Bart G, Koulman, Albert, Meierhofer, David, Melton, Phillip E, Mori, Trevor A, Snowden, Stuart G, van Mourik, Indra, Vreugdenhil, Anita, Wiegand, Susanna, Mann, Jake P
Published 2022

Variants in MTARC1 and HSD17B13 reduce severity of NAFLD in children and suppress fibrotic pathways through distinct mechanisms

by Hudert, Christian, Adams, Leon, Alisi, Anna, Anstee, Quentin, Crudele, Annalisa, Draijer, Laura, Furse, Samuel, Hengstler, Jan, Jenkins, Benjamin, Karnebeek, Kylie, Kelly, Deirdre, Koot, Bart, Koulman, Albert, Meierhofer, David, Melton, Phili, Mori, Trevor, Snowden, Stuart, van Mourik, Indra, Vreugdenhil, Anita, Weigand, Susanna, Mann, Jake
Published 2022